This conference will offer an overview of the latest innovations in European legislative activity and the most important recent case law and pending judgments of the Court of Justice of the European Union (CJEU) affecting the pharmaceutical sector:
Pharmaceutical law and competition law
- Pending CJEU rulings on Article 101 TFEU such as GSK (C-501/06) and on Article 102 such as AstraZeneca (T-321/05) and pending cases before the European Commission
- The way forward the pharmaceutical sector inquiry
Pharmaceutical law and intellectual property law
- Follow-up of the legislative proposal on counterfeiting of medicines (COM(2008)668)
- Pharmaceutical patent litigation settlements, patent linkage, licensing agreements
- Follow-up to the proposal for a unified patent litigation system
The future of pharmaceutical law in Europe
- New projects in the pipeline, including the current discussions on the clinical trial directive, follow-up of the 2008 pharmaceutical legislative package
- Emerging new technologies and legal status of borderline products
Fees in €:
|
Standard
|
EU and ERA patrons
|
Young lawyers and other groups
|
|
Registration
|
|
|
|
|
|
More details about the fees and discounts
Early registration discounts
10 % before 22.03.2010
Discounts available
25 % - For young lawyers up to 30 years of age (important: the participant must provide a copy or details of his or her passport or identity card on registration); Full-time staff of universities or comparable academic institutions; Staff of charitable organisations or comparable institutions; Employées of the Federal government and of the Cantons of Switzerland
40 % - Staff of European Union institutions and agencies;
Staff of ERA’s patrons (Austria, Bulgaria, Croatia, Cyprus, Czech Republic, Finland, France, Germany and the German states, Greece, Hungary, Ireland, Italy, Luxembourg, Malta, the Netherlands, Poland, Portugal, Romania, Scotland, Slovakia, Slovenia, Spain, Sweden, United Kingdom, City of Trier).